Affiliation:
1. Department of Vascular Surgery Xuanwu Hospital, Capital Medical University Beijing People's Republic of China
Abstract
AbstractTissue‐engineered blood vessel substitutes have been developed due to the lack of suitable small‐diameter vascular grafts. Xenogeneic extracellular matrix (ECM) scaffolds have the potential to provide an ideal source for off‐the‐shelf vascular grafts. In this study, porcine carotid arteries were used to develop ECM scaffolds by decellularization and coating with heparin and hepatocyte growth factor (HGF). After decellularization, cellular and nucleic materials were successfully removed with preservation of the main compositions (collagen, elastin, and basement membrane) of the native ECM. The ultimate tensile strength, suture strength, and burst pressure were significantly increased after cross‐linking. Pore size distribution analysis revealed a porous structure within ECM scaffolds with a high distribution of pores larger than 10 μm. Heparinized scaffolds exhibited sustained release of heparin in vitro and showed potent anticoagulant activity by prolonging activated partial thromboplastin time. The scaffolds showed an enhanced HGF binding capacity as well as a constant release of HGF as a result of heparin modification. When implanted subcutaneously in rats, the modified scaffolds revealed good biocompatibility with enzyme degradation resistance, mitigated immune response, and anti‐calcification. In conclusion, heparinized and HGF‐coated acellular porcine carotid arteries may be a promising biological scaffold for tissue‐engineered vascular grafts.
Funder
National Key Research and Development Program of China
Subject
Biomedical Engineering,Biomaterials
Reference46 articles.
1. Word Health Organization.Cardiovascular Diseases. Accessed August 31 2022.https://www.who.int/health-topics/cardiovascular-diseases
2. The use of expanded polytetrafluoroethylene (PTFE) grafts for myocardial revascularization;Hehrlein FW;J Cardiovasc Surg (Torino),1984
3. Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass